Clinical Trials Logo
  1. Home
  2. End Stage Renal Disease
  3. NCT02895425
  4. Details
NCT02895425 Clinical Trial

Registry for End Stage Renal Failure

End Stage Renal Failure Clinical Trial

— REIN  

Official title:
Réseau, Epidémiologie, Information, Néphrologie (Network Epidemiology Information Nephrology)

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT02895425
Other study ID # REIN
Secondary ID
Status Recruiting
Phase N/A
First received September 6, 2016
Last updated September 8, 2016
Start date January 2011
Est. completion date January 2021

Study information
Verified date September 2016
Source Centre Hospitalier de Cayenne
Contact n/a
Is FDA regulated No
Health authority France: Commission nationale de l'informatique et des libertés
Study type Observational [Patient Registry]

Clinical Trial Summary

The rein registry collects case record data from patients with end stage renal disease followed in French Guiana. This allows to generate incidence and rates for terminal renal disease, mortality rates for each territory. The regional data are pooled in order to get national statistics for end stage renal disease and transplantation activity in order to adapt prevention to the main causes of renal failure and treatment and care infrastructure.

Recruitment information / eligibility
Status Recruiting
Enrollment 1000
Est. completion date January 2021
Est. primary completion date January 2011
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- End Stage Renal Failure

Exclusion Criteria:

- Refusal to participate

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Intervention

Other:
• Registry (No intervention)

Locations
Country Name City State
France General Hospital of Cayenne Cayenne French Guiana

Sponsors (1)
Lead Sponsor Collaborator
Centre Hospitalier de Cayenne

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary Death 10 years No
Primary Transplant 10 years No
See also
  Status Clinical Trial Phase
Completed NCT01766882 - Volume,Sodium and Blood Pressure Management in HD N/A
Completed NCT01037595 - Effect of Turmeric on Pruritus in Hemodialysis Patients Phase 0
Completed NCT02686398 - Immunogenicity of a Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Undergoing Hemodialysis Phase 4
Active, not recruiting NCT04376567 - Outcomes for One-stage and Two-stage Brachial Basilic Arteriovenous Fistulas N/A
Completed NCT01990118 - Gengraf Conversion Study in Stable Renal Allograft Transplant Recipients Phase 4
Recruiting NCT01704313 - A Trial of Interrupted vs Continuous Suturing Techniques for Radiocephalic Fistulae N/A
Not yet recruiting NCT06389617 - Different Doses of Intravenous Administered Dexamethasone Effecting Brachial Plexus Supraclavicular Block N/A
Completed NCT01004627 - A Study of Routine Versus Selective Use of Ultrasound Scanning Prior to Haemodialysis Fistula Surgery N/A
Not yet recruiting NCT02341547 - Effectiveness of a Biosimilar Epoetin Alfa in Stable 'End Stage Renal Failure' N/A
Completed NCT01834755 - Physical and Psychological Profiles Associated With Patient's Preference for ESRD Treatment N/A
Completed NCT01101217 - Effect of Zinc Suplementation on Serum Hemosystein Level in Hemodialysis Patients N/A
Completed NCT01996930 - Steroid Impregnated Tape in the Treatment of Over-granulating Peritoneal Dialysis Exit Sites Phase 3
Not yet recruiting NCT01704339 - Qutenza for Critical Ischaemia in End Stage Renal Failure Phase 4
Recruiting NCT01781156 - Effect of Reducing Phosphorus Absorption on Cardiac Biomarkers in Hemodialysis Patients N/A
Completed NCT01906840 - Role of Turmeric on Oxidative Modulation in ESRD Patients Phase 1/Phase 2
Not yet recruiting NCT06378931 - Quality of Life Change in Patients Undergoing Parathyroidectomy With End-stage Renal Failure